Research study Program year 2020 Source: CMS Open Payments

Phase 2A Hepatic Impairment

Research payments

$5,101,113

626 payments

Through program year 2020, $5,101,113 in research payments was reported against Phase 2A Hepatic Impairment, across 626 payments, paid by Pfizer Inc..

Paid by: Pfizer Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$4,460,799	452
2019	Research	$640,314	174

Breakdown

Who paid Research payments · program years 2019–2020

Pfizer Inc. $5,101,113 626 payments

Who received the money Research payments · program years 2019–2020

National Research Institute Organisation paid for research $920,796 36 payments
Suncoast Research Group LLC Organisation paid for research $493,371 28 payments
Health Care Family Rehab Research Center Organisation paid for research $438,640 27 payments
Clinical Research of Miami Inc Organisation paid for research $261,847 26 payments
Finlay Medical Research Organisation paid for research $261,098 24 payments
Northeast Clinical Research Of San Antonio Organisation paid for research $259,021 25 payments
Hope Clinical Research Organisation paid for research $189,797 16 payments
Clinical Trials Of Texas INC Organisation paid for research $143,181 29 payments
Innovative Clinical Research INC Organisation paid for research $136,895 17 payments
Victorium Clinical Research Organisation paid for research $107,294 10 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.